| Formulary Chapter 11: Eye - Full Chapter
|
| Notes: |
Criteria for Preservative Free (PF) and Single Dose Unit (SDU) presentations:
These are restricted to patients with
• true preservative allergy
and/or
• evidence of epithelial toxicity from preservatives
and/or
• severe dry eyes
and/or
• require/ may require surgery in the near future
and/or
• neonates |
|
| Details... |
| 11.00 |
Antioxidants and Multivitamins for Age Related Macular Degeneration |
|
|
| 11.01 |
Administration of drugs to the eye |
|
|
| 11.02 |
Control of microbial contamination |
|
|
| 11.03 |
Anti-infective eye preparations |
|
|
| 11.03.01 |
Antibacterials |
|
|
Levofloxacin (Oftaquix)
|
Second Choice
|
Amber £££ 2nd line
Use SDU if using 1or 2 hourly or if significant OSD/toxicity.
|
|
|
Azithromycin (Azyter®)
|
Formulary
|
First line for ophthalmic chlamydia
|
|
|
Chloramphenicol
|
Formulary
|
0.5% eye drops First line
0.5% Minims (SDU)
1% eye ointment
|
 UKMI Q&A: Chloramphenicol: is it safe in breastfeeding?
|
Cefuroxime
|
Formulary
|
Hospital only
|
|
|
Ciprofloxacin 0.3%
(Eye drops )
|
Formulary
|
Specialist Ophthalmologist recommendation(Corneal consultant)
|
|
|
Fusidic Acid 1%
(M/R Eye Drops)
|
Formulary
|
NICU Use as per guideline -1st Line
Bacterial Conjunctivitis infection 2nd line as per Antimicrobial Guidelines
£££
|
|
|
Gentamicin 0.3% eye drops
|
Formulary
|
Possible 2nd Line after chloramphenicol- specialist opthalmologist recommendation.
|
|
|
Ofloxacin Eye drops 0.3%
|
Formulary
|
|
|
|
Penicillin 500o units in 1 ml eye drops
|
Formulary
|
Unlicensed
Hospital use only- Ophthalmologists
|
|
|
| 11.03.02 |
Antifungals |
|
|
Amphotericin (eye)
|
Formulary
|
|
|
|
Econazole 1% eye drops
|
Formulary
|
|
|
|
Miconazole 1% eye drops
|
Formulary
|
|
|
|
| 11.03.03 |
Antivirals |
|
|
Aciclovir 3% eye ointment
|
Formulary
|
|
|
|
Ganciclovir 0.15% ophthalmic gel (Virgan®)
|
Formulary
|
Specialist Ophthalmologist Recommendation.
|
|
|
Trifluorothymidine eye drops
|
Formulary
|
|
|
|
| 11.04 |
Corticosteroids and other anti-inflammatory preparations |
|
|
| 11.04.01 |
Corticosteroids |
|
|
Betamethasone 0.1% eye drops
|
Formulary
|
|
|
|
Betamethasone 0.1% eye ointment
|
Formulary
|
|
|
|
Betamethasone 0.1% with Neomycin 0.5% eye drops
|
Formulary
|
Short term use only
|
|
|
Dexamethasone 0.1% eye drops (Maxidex®)
|
Formulary
|
|
|
|
Dexamethasone 0.1% eye drops (Single dose units)
|
Formulary
|
for post corneal implants or OSD
Use the agent with the lowest acquisition cost
|
|
|
Dexamethasone with Antibacterials (Tobradex®)
|
Formulary
|
|
|
|
Dexamethasone with Neomycin and Polymyxin B sulphate (Maxitrol®)
(Eye Drops/Eye Ointment)
|
Formulary
|
Specialist Ophthalmologist Recommendation.
|
|
|
Fluorometholone 0.1% (FML®)
|
Formulary
|
Specialist Ophthalmologist Recommendation.
|
|
|
Loteprednol Etabonate 0.5% (Lotemax®)
|
Formulary
|
|
|
|
Prednisolone 0.5% eye drops
|
Formulary
|
Specialist Ophthalmologist Recommendation .
|
|
|
Prednisolone 1% eye drops (Pred Forte®)
|
Formulary
|
Specialist Ophthalmologist Recommendation.
For Anterior Uveitis in A&E-prednisolone acetate 1% as the drug of choice unless the patient has a preference for dexamethasone 0.1%
|
|
|
Prednisolone preservative free eye drops 0.5%
(Minims SDU)
|
Formulary
|
Specialist Ophthalmologist recommendation
Use in patients with severe Chronic Allergic Eye Disease who present to A&E with a flare up.
|
|
|
| 11.04.01 |
Intravitreal corticosteroids |
|
|
Dexamethasone 700mcg intravitreal implant (Ozurdex®)
|
 Restricted
|
For macular oedema secondary to retinal vein occlusion -use in line with NICE
For diabetic macular oedema- use in line with NICE
|
NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema
NICE TA349: Dexamethasone intravitreal implant for treatment of diabetic macular oedema
|
Fluocinolone intravitreal implant (Iluvien®)
|
Formulary
|
|
NICE TA301: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (rapid review of technology appraisal guidance 271)
|
| 11.04.02 |
Other anti-inflammatory preparations |
|
|
Sodium Cromoglicate 2% eye drops
|
First Choice
|
|
|
|
Olopatadine (Opatanol®)
|
Second Choice
|
2nd line £££
|
|
|
Azelastine (Optilast®)
|
Third Choice
|
|
|
|
Neodocromil 2% eye drps (Rapitil®)
|
Formulary
|
|
|
|
Sodium Cromoglicate 2% eye drops (preservative free)
|
Formulary
|
Specialist Ophthalmologist recommendation as Catacrom
|
|
|
| 11.05 |
Mydriatics and cycloplegics |
|
|
| 11.05 |
Antimuscarinics |
|
|
Atropine Sulphate 0.5% drops
|
Formulary
|
|
|
|
Atropine Sulphate 1% drops
|
Formulary
|
|
|
|
Atropine Sulphate single use (Minims® )
|
Formulary
|
Specialist Ophthalmologist Recommendation -used by glaucoma surgeons for neovascular glaucoma.
|
|
|
Cyclopentolate Hydrochloride 0.5% eye drops
|
Formulary
|
|
|
|
Cyclopentolate Hydrochloride 1% eye drops
|
Formulary
|
|
|
|
Cyclopentolate Hydrochloride single use (Minims® )
|
Formulary
|
Specialist Ophthalmologist Recommendation.
|
|
|
Tropicamide 0.5% and 1% (Mydriacyl®)
|
Restricted
|
Hospital only
|
|
|
Tropicamide single use (Minims® Tropicamide)
|
Restricted
|
Hospital only
|
|
|
| 11.05 |
Sympathomimetics |
|
|
Phenylephrine Hydrochloride (Minims® Phenylephrine Hydrochloride )
|
Formulary
|
|
|
|
| 11.06 |
Treatment of glaucoma |
|
|
|
|
| 11.06 |
Beta-blockers |
|
|
Betaxolol 0.25% eye drops
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Betaxolol 0.5% eye drops
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Betaxolol 0.5% Unit Dose Eye Drops
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Timolol 0.1% unit dose eye gel (Tiopex ®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
Once daily preparation
|
|
|
Timolol 0.25% eye drops
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Timolol LA 0.25% Eye Drops
|
Formulary
|
Specialist Ophthalmologist Recommendation
Once daily preparation
|
|
|
| 11.06 |
Prostaglandin analogues |
|
|
Latanoprost eye drops
|
Formulary
|
Specialist Ophthalmologist Recommendation
1st Line
|
|
|
Bimatoprost 0.01% eye drops
|
Formulary
|
Specialist Ophthalmologist Recommendation.
2nd line
|
|
|
Bimatoprost with Timolol (Ganfort®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Latanoprost 0.005% with Timolol 0.5%
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Latanoprost PF Eye Drops (Monopost)
|
Formulary
|
Specialist Ophthalmologist Recommendation
1st Line PF option
|
|
|
Tafluprost (Preservative Free) 15micrograms/ml
|
Formulary
|
Specialist Ophthalmologist Recommendation
2nd line PF option
|
|
|
| 11.06 |
Sympathomimetics |
|
|
Brimonidine Tartrate
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Brimonidine Tartrate 0.2% with Timolol 0.5% (Combigan®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
| 11.06 |
Carbonic anhydrase inhibitors and systemic drugs |
|
|
Acetazolamide
(Tablets)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Acetazolamide
(Injection)
|
Formulary
|
Hospital Only
|
|
|
Acetazolamide M/R
(capsules)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Brinzolamide 10mg/ml
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Brinzolamide 10mg/ml with Timolol 5mg/ml
|
Formulary
|
Specialist Ophthalmologist Recommendation
2nd/3rd line
|
|
|
Dorzolamide 2%
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Dorzolamide 2% eye drops (SDU) (Trusopt®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Brinzolamide 10mg/ml with Brimonidine 2mg/ml (Simbrinza® )
|
Formulary
|
Specialist Ophthalmologist Recommendation
Third line option, after prostaglandin analogues (1st line) and beta-blocker/ prostaglandin analogue plus beta-blocker (2nd line)
For patients in whom monotherapy provides insufficient IOP reduction.
|
|
|
Dorzolamide 2% with Timolol 0.5%
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Dorzolamide 2% with Timolol 0.5% SDU Eye Drops (Cosopt®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
| 11.06 |
Miotics |
|
|
Pilocarpine 1%,2% and 4% eye drops
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Pilocarpine preservative free
(Single dose units)
|
Restricted
|
Hospital only
|
|
|
| 11.07 |
Local anaesthetics |
|
|
| 11.08 |
Miscellaneous ophthalmic preparations |
|
|
| 11.08.01 |
Tear deficiency, ocular lubricants, and astringents |
|
|
Xailin Night
|
First Choice
|
|
|
|
VitA POS eye ointment
|
Second Choice
|
|
|
|
Acetylcysteine 5% with Hypromellose 0.35% (Ilube®)
|
Formulary
|
|
|
|
Acetylcysteine 10% eye drops
|
Formulary
|
|
|
|
Carbomers (Clinitas Gel®)
|
Formulary
|
Clinitas Gel does not have benzalkonium chloride (BAK) as a preservative. It is preserved with cetrimide.
|
|
|
Carmellose 0.5% SDU (Xailin Fresh ®)
|
Formulary
|
|
|
|
Carmellose1% multi (Moorfields)
|
Formulary
|
|
|
|
Hypromellose 0.5% eye drops
|
Formulary
|
All other strengths are non formulary
|
|
|
Sodium Chloride (Minims® Saline)
|
Restricted
|
Hospital only. Diluent for impregnated dye strips
|
|
|
Sodium Chloride 0.9% Solutions
|
Restricted
|
Hospital only- Theatre use
|
|
|
Sodium Chloride 5% eye ointment
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Sodium Chloride 5% PF drops (Moorfields)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Sodium Hyaluronate 0.15% Multi (Hyabak®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Sodium Hyaluronate 0.2% eye drops PF (Evolve HA ®)
|
Formulary
|
- Specialist Ophthalmologist Recommendation
Approved onto formulary January 2019
|
|
|
Sodium Hyaluronate 0.2% PF Multi (Hylo-Forte®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
|
|
|
Sodium Hyaluronate 0.4% SDU (Clinitas®)
|
Formulary
|
Specialist Ophthalmologist Recommendation
Each preservative-free unit is resealable and may be used for up to 12 hours.
|
|
|
Viscotears eye drops
|
Formulary
|
|
|
|
Viscotears Liquid gel single dose units
|
Formulary
|
|
|
|
Xailin gel
|
Formulary
|
|
|
|
| 11.08.02 |
Ocular diagnostic and peri-operative preparations and photodynamic treatment |
|
|
| 11.08.02 |
Ocular diagnostic preparations |
|
|
| 11.08.02 |
Ocular peri-operative drugs |
|
|
Apraclonidine 1% SDU eye drops
|
Formulary
|
only PF sympathomimetic
|
|
|
Apraclonidine 0.5%
(eye drops)
|
Formulary
|
|
|
|
Bromfenac (Yellox®)
|
Formulary
|
Approved January 2018. Interim measure due to supply issues with ketorolac eye drops
|
|
|
Diclofenac (Voltarol® Ophtha SDU)
|
Formulary
|
|
|
|
Diclofenac Sodium (Voltarol® Ophtha multidose)
|
Formulary
|
|
|
|
Ketorolac (Acular®)
|
Formulary
|
|
|
|
| 11.08.02 |
Subfoveal choroidal neovascularisation |
|
|
Aflibercept (Eylea®)
|
Restricted
|
Use in line with NICE
|
NICE TA 486: Aflibercept for treating choroidal neovascularisation
NICE TA409: Visual impairment caused by macular oedema after branch retinal vein occlusion- aflibercept.
NICE TA346: Macular oedema (diabetic)- aflibercept
NICE TA305: Macular oedema (retinal vein occlusion)- aflibercept
NICE TA294: Macular degeneration (wet age-related) - aflibercept
|
Bevacizumab intravitreal injection (Avastin®)
|
Formulary
|
|
|
|
Ranibizumab (Lucentis®)
|
Restricted
|
Use in line with NICE
|
NICE TA155: Age-related Macular Degeneration- ranibizumab
NICE TA274: Macular oedema (diabetic) - ranibizumab
NICE TA283: Macular oedema (retinal vein occlusion) - ranibizumab: guidance
NICE TA298: Choroidal neovascularisation (pathological myopia) - ranibizumab
|
Verteporfin (Visudyne®)
|
Restricted
|
|
NICE TA68: photodynamic therapy (PDT) to treat age-related macular degeneration (ARMD).
|
| 11.08.02 |
Vitreomacular traction |
|
|
Ocriplasmin (Jetrea®)
|
Restricted
|
|
NICE TA297: Ocriplasmin for treating vitreomacular traction
|
| 11.09 |
Contact lenses |
|
|
| 11.99.99.99 |
Miscellaneous |
|
|
| 11.99.99.99 |
Eyelid wipes |
|
|
| 11.99.99.99 |
Cytotoxics / wound healing modulators |
|
|
Fluorouracil
|
Restricted
|
hospital only
|
|
|
Mitomycin C
|
Restricted
|
Hospital only
|
|
|
| 11.99.99.99 |
Fibrinolytic drugs |
|
|
| 11.99.99.99 |
Glues - ocular |
|
|
| 11.99.99.99 |
Immunosuppressants |
|
|
Ciclosporin 1 mg/mL eye drops, emulsion (Ikervis®)
|
Formulary
|
Specialist initiation.
In line with NICE
|
NICE TA369: Ciclosporin for treating dry eye disease (Dec 2015)
|
Adalimumab (Humira®)
|
Formulary
|
In line with NICE
|
NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis
|
Ciclosporin 2mg/g eye ointment (Optimmune®)
|
Formulary
|
|
|
|
| 11.99.99.99 |
Treatment of burns |
|
|
| 11.99.99.99 |
Visco-elastics |
|
|
| 11.99.99.99 |
Other |
|
|
Hyaluronidase (Hyalase®)
|
Restricted
|
Hospital only
|
|
|
| .... |
| Non Formulary Items |
Acetylcholine Chloride (Miochol-E®)
|
Non Formulary
|
|
|
|
Alteplase intravitreal injection
|
Non Formulary
|
|
|
|
Amikacin
|
Non Formulary
|
|
|
|
Amo Complete
|
Non Formulary
|
|
|
|
Antazoline 0.5% with Xylometazoline 0.05% (Otrivine-Antistin®)
|
Non Formulary
|
|
|
|
Boston Advance Cleaner
|
Non Formulary
|
|
|
|
Boston Advance Conditioning Solution
|
Non Formulary
|
|
|
|
Brilliant Peel®
|
Non Formulary
|
|
|
|
Carbomers (GelTears®)
|
Non Formulary
|
|
|
|
Carbomers (Liposic®)
|
Non Formulary
|
|
|
|
Carbomers (liquivisc®)
|
Non Formulary
|
|
|
|
Carmellose Sodium (Carmize®)
|
Non Formulary
|
|
|
|
Carmellose1% SDU (Celluvisc®)
|
Non Formulary
|
|
|
|
Carteolol (Teoptic®)
|
Non Formulary
|
|
|
|
Ceftazidime
|
Non Formulary
|
|
|
|
Chlorhexidine
|
Non Formulary
|
|
|
|
Chlortetracycline
|
Non Formulary
|
|
|
|
Ciprofloxacin 0.3%
(eye ointment)
|
Non Formulary
|
Discontinued May 2017 |
|
|
Cocaine
|
Non Formulary
|
|
|
|
Dexamethasone with Antibacterials (Sofradex®)
|
Non Formulary
|
|
|
|
Dipivefrine Hydrochloride (Propine®)
|
Non Formulary
|
|
|
|
Disodium Edetate 0.37%
|
Non Formulary
|
|
|
|
Emedastine (Emadine®)
|
Non Formulary
|
|
|
|
Epinastine (Relestat®)
|
Non Formulary
|
|
|
|
Erythromycin
|
Non Formulary
|
|
|
|
Eyelid wipes for blepharitis
|
Non Formulary
|
Blephaclean Sterile Eyelid wipes
Supranettes Sterile Eye-cleansing wipes |
|
|
Fluorescein (Anatera®)
|
Non Formulary
|
|
|
|
Fluorescein Sodium
|
Non Formulary
|
|
|
|
Flurbiprofen Sodium (Ocufen®)
|
Non Formulary
|
|
|
|
Foscarnet intravitreal injection
|
Non Formulary
|
|
|
|
Ganciclovir intravitreal injection
|
Non Formulary
|
|
|
|
Gentamicin single use (Minims® Gentamicin Sulphate)
|
Non Formulary
|
Discontinued |
|
|
Glycerol (glycerin)
|
Non Formulary
|
|
|
|
Homatropine Hydrobromide
|
Non Formulary
|
|
|
|
Hydrocortisone Acetate with Neomycin (Neo-Cortef®)
|
Non Formulary
|
|
|
|
Hydrocortisone eye ointment
|
Non Formulary
|
|
|
|
Hydroxyethylcellulose (Minims® Artificial Tears)
|
Non Formulary
|
|
|
|
Hydroxypropyl Guar (Systane®)
|
Non Formulary
|
Except for existing patients |
|
|
Hypromellose 0.3% eye drops
|
Non Formulary
|
|
|
|
Hypromellose 0.3% with Dextran 70 0.1% (Tears naturale®)
|
Non Formulary
|
|
|
|
Hypromellose 1% eye drops
|
Non Formulary
|
|
|
|
Hypromellose preservative free ( SDU)
|
Non Formulary
|
|
|
|
Indocyanine green
|
Non Formulary
|
|
|
|
Ketotifen (Zaditen®)
|
Non Formulary
|
|
|
|
Levobunolol
|
Non Formulary
|
|
|
|
Lidocaine Hydrochloride 4% with Fluorescein 0.25% (Minims®)
|
Non Formulary
|
|
|
|
Liquid Paraffin (Lacri-Lube®)
|
Non Formulary
|
|
|
|
Lodoxamide (Alomide®)
|
Non Formulary
|
|
|
|
Lubristil ®gel
|
Non Formulary
|
|
|
|
Metipranolol (Minims® Metipranolol)
|
Non Formulary
|
|
|
|
Multivitamins and antioxidants
|
Non Formulary
|
e.g. Icaps,Vitalux Plus, Macushield, Ocuvite All non formulary
Please refer to section 9.06.07
|
|
|
Neomycin Sulphate with antibacterials (Neosporin®)
|
Non Formulary
|
|
|
|
Nepafenac (Nevanac®)
|
Non Formulary
|
|
|
|
Oxybuprocaine Hydrochloride (Minims® )
|
Non Formulary
|
|
|
|
Oxysept 1 Step
|
Non Formulary
|
|
|
|
Paraffin Yellow Soft (Simple Eye Ointment)
|
Non Formulary
|
Replaced by Xailin Night or VitA-POS |
|
|
Pegaptanib Sodium (Macugen®)
|
Non Formulary
|
|
NICE TA155: guidance on pegaptanib in AMD (August 2008)
|
Phenylephrine Hydrochloride (Mydriasert®)
|
Non Formulary
|
|
|
|
Pilocaprine long acting (Pilogel®)
|
Non Formulary
|
|
|
|
Polihexanide
|
Non Formulary
|
|
|
|
Polymyxin B Sulphate eye ointment (Polyfax®)
|
Non Formulary
|
|
|
|
Polyvinyl Alchohol Single Dose Units (Liquifilm Tears®)
|
Non Formulary
|
|
|
|
Polyvinyl Alcohol (Sno Tears or Liquifilm Tears ®)
|
Non Formulary
|
|
|
|
Potassium Ascorbate
|
Non Formulary
|
|
|
|
Povidone (Oculotect®)
|
Non Formulary
|
|
|
|
Prednisolone 0.5% with Neomycin 0.5% (Predsol-N®)
|
Non Formulary
|
|
|
|
Propamidine Isetionate (Brolene®)
|
Non Formulary
|
|
|
|
Proxymetacaine Hydrochloride (Minims®)
|
Non Formulary
|
|
|
|
Rimexolone (Vexol®)
|
Non Formulary
|
|
|
|
Rose Bengal (Minims® Rose Bengal)
|
Non Formulary
|
|
|
|
Saline Solution
|
Non Formulary
|
|
|
|
Sodium Citrate
|
Non Formulary
|
|
|
|
Sodium Hyaluronate (Hylo-Tear®)
|
Non Formulary
|
|
|
|
Sodium Hyaluronate (Vismed® Gel and SDU)
|
Non Formulary
|
|
|
|
Sodium Hyaluronate (Vismed® multi)
|
Non Formulary
|
|
|
|
Sodium Hyaluronate with Lidocaine
|
Non Formulary
|
|
|
|
Soybean oil unit dose eye drops (Emustil®)
|
Non Formulary
|
|
|
|
Tear flow test strips
|
Non Formulary
|
|
|
|
Tetracaine Hydrochloride (Minims® Amethocaine Hydrochloride)
|
Non Formulary
|
|
|
|
Timolol 0.25% single dose units
|
Non Formulary
|
|
|
|
Timolol 0.5% eye drops
|
Non Formulary
|
Not for new patients, existing patients to remain on treatment. |
|
|
Timolol 0.5% single dose units
|
Non Formulary
|
|
|
|
Timolol LA 0.5% Eye Drops
|
Non Formulary
|
Not for new patients
Existing patients to remain on treatment |
|
|
Timolol Once-daily (Nyogel®)
|
Non Formulary
|
|
|
|
Tissue Adhesive (Histacryl®)
|
Non Formulary
|
|
|
|
Total Care Daily Cleaner
|
Non Formulary
|
|
|
|
Total Care Disinfecting and Wetting Solution
|
Non Formulary
|
|
|
|
Travoprost (Travatan®)
|
Non Formulary
|
|
|
|
Travoprost with Timolol (DuoTrav®)
|
Non Formulary
|
|
|
|
Vancomycin
|
Non Formulary
|
|
|
|
Viscoat Viscoelastic
|
Non Formulary
|
|
|
|
Zinc Sulphate
|
Non Formulary
|
|
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications. |
|
Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.
Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements. |
|
Medicines for initiation and maintenance prescribing by Specialists only |
|
Non-formulary medicines- medicines not recommended for routine primary care prescribing. |
|
Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information. |
|
|
|
